Table 1.
Baseline characteristics | Mean or % |
---|---|
Age | 51.94 (SD = 10.30) |
Gender (female) | 55.9% (n = 19) |
Race | |
White | 88.2% (n = 30) |
Black | 8.8% (n = 3) |
Hispanic | 2.9% (n = 1) |
Cancer site | |
Breast | 38.2% (n = 13) |
Head and neck | 32.4% (n = 11) |
Lung | 29.4% (n = 10) |
Cancer treatmenta (n = 19) | |
Chemotherapy | 36.8% (n = 7) |
Hormone therapy | 21.1% (n = 4) |
Radiation therapy | 15.8% (n = 3) |
Multiple therapies | 26.3% (n = 5) |
aIndicates those participants who were undergoing active cancer treatment during the 2-week study period.